F Zipp Selected Research

Brain Injuries (Brain Injury)

1/2003

Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Zipp Research Topics

Disease

22	Multiple Sclerosis 12/2018 - 02/2000
4	Autoimmune Diseases (Autoimmune Disease) 02/2008 - 10/2000
3	Chronic Progressive Multiple Sclerosis 12/2018 - 02/2007
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2015 - 02/2000
2	Progressive Multifocal Leukoencephalopathy 12/2018 - 10/2011
2	Demyelinating Diseases (Demyelinating Disease) 11/2011 - 01/2003
2	Cardiotoxicity 01/2009 - 02/2007
1	Posterior Leukoencephalopathy Syndrome 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Listeria Meningitis 12/2018
1	Encephalitis (Encephalitis, Rasmussen) 12/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2018
1	Liver Failure 12/2018
1	Disease Progression 12/2015
1	Atrophy 04/2014
1	Astrocytoma (Pilocytic Astrocytoma) 11/2011
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2010
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2009
1	Cognitive Dysfunction 11/2009
1	Heart Failure 09/2009
1	Cardiomyopathies (Cardiomyopathy) 09/2009
1	Ankylosing Spondylitis 09/2008
1	Neuromyelitis Optica (Devic's Disease) 05/2008
1	Arthritis (Polyarthritis) 02/2008
1	Neuroinflammatory Diseases 02/2008
1	Seizures (Absence Seizure) 06/2006
1	Leukoencephalopathies 06/2006
1	Stomach Neoplasms (Stomach Cancer) 06/2006
1	Encephalomyelitis (Myeloencephalitis) 01/2003
1	Brain Injuries (Brain Injury) 01/2003
1	Rhabdomyolysis 02/2002
1	Hepatitis B 10/2001
1	Disease Susceptibility (Diathesis) 10/2000
1	Necrosis 09/2000

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 01/2010 - 02/2000
4	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2009 - 02/2007
2	Natalizumab (Tysabri)FDA Link 12/2018 - 10/2011
1	VemurafenibIBA 01/2019
1	cobimetinibIBA 01/2019
1	ocrelizumabIBA 12/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 12/2018
1	Alemtuzumab (Campath)FDA Link 12/2018
1	Daclizumab (Zenapax)FDA Link 12/2018
1	Cladribine FDA LinkGeneric 12/2018
1	Apolipoproteins E (ApoE)IBA 12/2015
1	ApolipoproteinsIBA 12/2015
1	laquinimodIBA 04/2014
1	CuprizoneIBA 11/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2011
1	Immunoglobulin M (IgM)IBA 01/2010
1	Immunoglobulin G (IgG)IBA 01/2010
1	GadoliniumIBA 11/2009
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2009
1	AnthraquinonesIBA 01/2009
1	Antineoplastic Agents (Antineoplastics)IBA 01/2009
1	AnthracyclinesIBA 01/2009
1	Etanercept (Enbrel)FDA Link 09/2008
1	KininsIBA 02/2008
1	ChemokinesIBA 11/2006
1	Fluorouracil (Carac)FDA LinkGeneric 06/2006
1	Cisplatin (Platino)FDA LinkGeneric 06/2006
1	EpitopesIBA 01/2003
1	Interferon beta-1a FDA Link 02/2002
1	VaccinesIBA 10/2001
1	CytokinesIBA 08/2001
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2001
1	Immunoglobulins (Immunoglobulin)IBA 03/2001
1	Myelin Basic ProteinIBA 11/2000
1	GlucocorticoidsIBA 10/2000
1	HLA-DR Antigens (HLA-DR)IBA 10/2000
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 10/2000
1	Amino Acids FDA Link 10/2000
1	Pharmaceutical PreparationsIBA 09/2000
1	LigandsIBA 09/2000
1	bisindolylmaleimideIBA 02/2000

Therapy/Procedure

12	Therapeutics 01/2019 - 09/2000
5	Immunotherapy 12/2018 - 11/2004
1	Aftercare (After-Treatment) 08/2009
1	Drug Therapy (Chemotherapy) 06/2006